Showing 2111-2120 of 2235 results for "".
- Sciton Targets Veins, Skin, and Hair with Clear Suite Familyhttps://modernaesthetics.com/news/sciton-targets-veins-skin-and-hair-with-clear-suite-family/2471876/Sciton Inc. is launching its Clear Suite family of products. The Clear Suite offerings make the JOULE platform customizable. Utilizing the 1064 Nd:YAG wavelength, the Clear Suite family of products, including ClearV, ClearSilk, and ClearHair, combined with BroadBand Light (BBL), allo
- Viper Equity Partners Moves Plastic Surgery Into Consolidation Mainstream with Another Marquis Dealhttps://modernaesthetics.com/news/viper-equity-partners-moves-plastic-surgery-into-consolidation-mainstream-with-another-marquis-deal/2471886/Plastic Surgery is moving into the consolidation Mainstream with another marquis deal by Viper Equity Partners of Palm Beach, FL. Viper was instrumental in a Marquis deal merging their client Aqua Plastic Surgery with Water's Edge Derma
- ASPS: Daddy-Do-Overs Are On The Risehttps://modernaesthetics.com/news/asps-daddy-do-overs-are-on-the-rise/2471898/More than 1.3 million cosmetic procedures were performed on men last year alone, representing a 29 percent increase since 2000, according to a new report from the American Society of Plastic Surgeons. With more than 200,000 surgical procedures performed on men in 2018, rhinoplasty was the
- Revance Appoints Brand Strategist Jill Beraud to Board of Directorshttps://modernaesthetics.com/news/revance-appoints-brand-strategist-jill-beraud-to-board-of-directors/2471899/Jill Beraud is now a member of Revance Therapeutics, Inc.'s Board of Directors. Ms. Beraud brings more than 25 years’ experience building luxury, fashion, beauty, and consumer brands. Ms. Beraud will also chair a newly-formed Revance Brand St
- 2018 BAAPS Data: Liposuction Up by 9 Percent in 2018https://modernaesthetics.com/news/2018-baaps-data-liposuction-up-by-9-percent-in-2018/2471908/More than 28,000 cosmetic surgery procedures took place in the UK in 2018, an increase of less than 1 percent from 2017, according to the annual stats from the British Association of Aesthetic Plastic Surgeons (
- New Standard of Care Proposed for Brazilian Butt Liftshttps://modernaesthetics.com/news/new-standard-of-care-proposed-for-brazilian-butt-lifts/2471910/Brazilian butt lifts are safe only if the injections remain in the subcutaneous tissue, suggests a new study in the May issue of Plas
- New Soft Tissue Substitute Shows Promise for Correcting Defectshttps://modernaesthetics.com/news/new-soft-tissue-substitute-may-help-patients-avoid-certain-surgeries/2471918/A newly invented synthetic soft tissue substitute may hold advantages over currently available fillers, fat and implants when treating defects. The new composite is well tolerated and encourages the growth of soft tissue and blood vessels. It also retains its shape without being too dense
- Galderma's Dysport Celebrates 10 Years Since FDA Approvalhttps://modernaesthetics.com/news/dysport-celebrates-10-years-since-fda-approval/2471921/Galderma Laboratories’ Dysport (abobotulinumtoxinA) is ringing in its 10th birthday. To celebrate this milestone, Galderma is offering double points for Dysport aesthetic treatments registered in
- New Study Highlights Risks of Energy-Based Vaginal Rejuvenationhttps://modernaesthetics.com/news/new-study-highlights-risks-of-energy-based-vaginal-rejuvenation/2471923/Concerns from the federal Food and Drug Administration (FDA) sired the first assessment of adverse events related to device procedures marketed for ‘vaginal rejuvenation,’ and the new analysis of the Manufacturer and User Facility Device Experience (MAUDE) database identified a total
- Sadick and Sadick Featured at Cutera Beauty Talkhttps://modernaesthetics.com/news/sadick-and-sadick-featured-at-cutera-beauty-talk/2471934/Dermatologist Neil Sadick MD and his daughter Sydney Sadick, an in the know fashion journalist, talked about everything from state-of-the-art skin brightening treatments to the newest injectables and how to get svelte without sweating or surgery at